Delphinus 2026-I: 27 June 2026

A stand-alone transaction, where the Issuer will make payments on the Notes from payments of principal and interest received from a portfolio comprising mortgage loans originated by the Seller (ASR Levensverzekering) and secured over residential properties located in the Netherlands.

At the cut-off date (1 May 2026) the receivables portfolio consists of 2,549 mortgages in 7,603 loan parts secured by owner-occupier properties located in the Netherlands. The average loan balance per loan is Eur247,775. On the cut-off date no amounts due and payable under any of the mortgage loans were overdue and unpaid. Mortgage redemption type (by current balances): annuity - 55.95%, interest-only – 26.37%, bank savings – 14.64% and others - 3.04%. Interest rate type (by current balances): fixed - 99.09%, floating - 0.91%. The WA CLTOMV is 78.21% and the WA CLTIFV is 66.39%. The WA seasoning is 6.03 years. Regional concentration: Zuid-Holland - 20.59%, Noord Brabant - 15.02%, Gelderland - 14.49%, Noord-Holland – 13.11% and Utrecht - 8.23%.

EU & UK Risk Retention: The Seller, as Originator within the meaning of Article 6 of the Securitisation Regulation, has undertaken to retain on an ongoing basis a material net economic interest of not less than 5% in the securitisation transaction in accordance with Article 6 of the Securitisation Regulation, and in accordance with Article 6 of the UK Securitisation Regulation as if it were applicable to it.

US Risk Retention: Neither the Seller nor any other party intends to retain at least 5% of the credit risk of the securitised assets within the meaning of, and for purposes of compliance with, the US Risk Retention Rules, but rather intends to rely on an exemption provided for in section 20 of the US Risk Retention Rules regarding non-US transactions that meet certain requirements.

STS: The securitisation transaction is intended to qualify as a STS securitisation within the meaning of Article 18 of the Securitisation Regulation.

Compare/contrast: Delphinus 2025-I, Candide Financing 2026-1 BV, Jubilee Place 9 BV